Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.1K
Overview
45.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

158
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
158
Immunological Memory01:23

Immunological Memory

2.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
2.9K
Development of Immunocompetence01:22

Development of Immunocompetence

414
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
414
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

162
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
162
Rh Blood Group01:19

Rh Blood Group

1.6K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dolutegravir concentrations in children receiving 3-month weekly isoniazid and rifapentine (3HP) for tuberculosis prevention.

Microbiology spectrum·2026
Same author

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Emerging infectious diseases·2026
Same author

Phase 2C clinical trial of novel short-course regimens for the treatment of pulmonary tuberculosis: TBTC study 38/CRUSH-TB design.

Contemporary clinical trials·2025
Same author

On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000-2023, Namibia.

Vaccines·2024
Same author

Progress with the Second Dose Measles Vaccine Introduction and Coverage in the WHO African Region.

Vaccines·2024
Same author

Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.

MMWR. Morbidity and mortality weekly report·2024

Related Experiment Video

Updated: Aug 17, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.3K

Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.

Meredith G Dixon, Susan E Reef, Laura A Zimmerman

    Emerging Infectious Diseases
    |December 11, 2022
    PubMed
    Summary

    Lessons from the rubella vaccine program offer insights for COVID-19 vaccine strategies. Key elements include clear goals, data-driven revisions, and effective surveillance for disease control.

    Keywords:
    COVID-19Rubella vaccinationSARS-CoV-2coronavirus diseaserespiratory infectionssevere acute respiratory syndrome coronavirus 2vaccine-preventable diseasesviruseszoonoses

    More Related Videos

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
    08:52

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

    Published on: February 22, 2019

    10.8K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.0K

    Related Experiment Videos

    Last Updated: Aug 17, 2025

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
    07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.3K
    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
    08:52

    Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

    Published on: February 22, 2019

    10.8K
    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
    09:14

    An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

    Published on: January 26, 2019

    11.0K

    Area of Science:

    • Vaccinology
    • Epidemiology
    • Public Health

    Background:

    • The 1963-1965 rubella epidemic spurred vaccine development.
    • Rubella vaccine is now used globally, eliminating the disease in 93 countries.

    Purpose of the Study:

    • To identify lessons from rubella vaccine implementation applicable to COVID-19 vaccine rollout.
    • To highlight critical components of successful vaccination programs.

    Main Methods:

    • Comparative analysis of rubella and COVID-19 vaccine implementation strategies.
    • Review of historical rubella disease control program data and outcomes.

    Main Results:

    • Rubella vaccine introduction, though slower than COVID-19 vaccines, provides valuable insights.
    • Successful vaccination programs require clear goals, data-driven adjustments, and robust surveillance.

    Conclusions:

    • Implementing COVID-19 vaccines can benefit from the strategic and data-driven approaches used in rubella control.
    • Continuous evaluation and adaptation are crucial for achieving vaccination targets and disease elimination.